Apartment complexes in Richmond for $3 million and $1.7 million topped this week’s sales and 5,612 square feet in Henrico was the top lease.
BizSense Pro
The Docket: Local court roundup for 5.27.21
Officers and directors of a Fortune 500 company are sued for $5 million in a shareholder derivative action. An ousted CEO says he is owed $65,000 in severance. BizSense Pro members have access to the entire docket.
Breaking Ground: Local building permits for 5.26.21
FedEx has a $9 million project in Chesterfield. Richmond reports more work in Scotts Addition. For the entire list of permits, become a BizSense Pro member.
The Pitch: Advertising and marketing news for 5.25.21
A public health campaign promotes COVID vaccinations, a tourism group releases new ads, and a PR firm secures media coverage of an excavation project in Colonial Williamsburg.
The Herd: New hires, promotions & departures for 5.25.21
The president of a real estate development firm is retiring, a law firm adds partners, and new faces and promotions in real estate, finance, construction and more.
The Agenda: Local government briefs for 5.24.21
The Richmond City Council nears a vote on the FY22 budget, Petersburg hires a city manager, and 210 townhomes at Westchester Commons get a thumbs-up.
The Pipeline: Commercial real estate roundup for 5.21.21
The $9.3 million sale of 246,615 square in Richmond tops the list this week and 55,957 square feet to a printing company in Henrico is the top lease.
Trading Day: Local SEC filings for 5.20.21
Proxy season continues as CarMax discloses its executive compensation data. Plus, a local REIT drops $10 million for a shopping center in South Carolina.
The Docket: Local court roundup for 5.20.21
A property investor says he got nothing for his $100,000 and alleges fraud. A shopper claims slander, denying he told an employee that he wanted to fight her. BizSense Pro members have access to the entire docket.
The R&D Dept.: Local patents for 5.19.21
Genomic testing status, authentication of potentially fraudulent transactions and cancer invasion inhibitors are just some of he ideas on this week’s list.